D
David S. Rampton
Researcher at Barts Health NHS Trust
Publications - 1
Citations - 106
David S. Rampton is an academic researcher from Barts Health NHS Trust. The author has contributed to research in topics: Pharmacogenetics & Thiopurine methyltransferase. The author has an hindex of 1, co-authored 1 publications receiving 70 citations.
Papers
More filters
Journal ArticleDOI
Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease.
Gareth J. Walker,Gareth J. Walker,James W. Harrison,Graham A. Heap,Graham A. Heap,Michiel Voskuil,Vibeke Andersen,Carl A. Anderson,Ashwin N. Ananthakrishnan,Jeffrey C. Barrett,Laurent Beaugerie,Claire Bewshea,Andy Cole,Fraser Cummings,Mark J. Daly,Pierre Ellul,Richard N. Fedorak,Eleonora A. M. Festen,Timothy H. Florin,Daniel R. Gaya,Jonas Halfvarson,Ailsa L. Hart,Neel Heerasing,Neel Heerasing,Peter Hendy,Peter Hendy,Peter M. Irving,Samuel E. Jones,Jukka Koskela,James O. Lindsay,John C. Mansfield,Dermot P.B. McGovern,Miles Parkes,Richard Pollok,Subramaniam Ramakrishnan,David S. Rampton,Manuel A. Rivas,Richard K Russell,Michael Schultz,Shaji Sebastian,Philippe Seksik,Abhey Singh,Kenji So,Harry Sokol,Kavitha Subramaniam,Anthony Todd,Vito Annese,Rinse K. Weersma,Ramnik J. Xavier,Rebecca H. R. Ward,Michael N. Weedon,James R Goodhand,James R Goodhand,Nicholas A. Kennedy,Nicholas A. Kennedy,Tariq Ahmad,Tariq Ahmad +56 more
TL;DR: The findings suggest that NUDT15 genotyping may be considered prior to initiation of thiopurine therapy; however, further study including additional validation in independent cohorts is required.